Understanding Rem Sleep Disorders: Causes And Treatments

REM sleep behaviour disorder (RBD) is a parasomnia in which affected individuals act out their dreams while in the REM stage of sleep. This can involve violence and can lead to injury to the self or others without conscious awareness. RBD is usually seen in middle-aged to elderly people and more often in men. The exact cause of RBD is unknown, but it may happen alongside degenerative neurological conditions such as Parkinson's disease, Lewy body dementia, and Shy-Drager syndrome. RBD can also be brought on by antidepressants, alcohol, or sedative-hypnotic drugs.

REM sleep behaviour disorder (RBD) is a parasomnia involving dream enactment

REM sleep behaviour disorder (RBD) is a parasomnia that involves dream enactment. During normal REM sleep, the body experiences temporary paralysis, known as atonia, while the brain shows activity similar to wakefulness. However, for individuals with RBD, this paralysis does not occur, allowing them to physically act out their dreams. This can include talking, yelling, punching, kicking, sitting up, jumping from bed, arm flailing, and grabbing. The dreams associated with RBD are often vivid, intense, and frightening, and individuals may dream about being chased or attacked.

RBD is relatively rare, affecting between 0.5 to 1% of adults, and is more common in men and adults over 50. The exact cause of RBD is unknown, but it has been linked to the use of certain medications, including antidepressants, and the development of neurodegenerative diseases such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. RBD can also be secondary to narcolepsy.

The diagnosis of RBD requires confirmation through an in-laboratory sleep study, which helps to identify abnormal behaviours during REM sleep and exclude other sleep disorders. Treatment for RBD aims to reduce the risk of injury to the patient and their bed partner and may include lifestyle changes, medication such as melatonin or clonazepam, and injury prevention techniques.

RBD can be a disturbing disorder for both patients and their bed partners, and it is important to create a safe sleeping environment to avoid injuries. Healthcare professionals play a crucial role in educating patients and their partners about the disorder and providing appropriate treatment and management options.

RBD is strongly linked to neurodegenerative diseases

REM sleep behaviour disorder (RBD) is a parasomnia involving dream enactment behaviour associated with a loss of muscle atonia during REM sleep. RBD is strongly linked to neurodegenerative diseases, particularly synucleinopathies. The prevalence of RBD in the general population is estimated to be between 0.38% and 2.01%, but this figure is much higher in patients with neurodegenerative diseases.

RBD is characterised by excessive muscle activity during REM sleep, typically associated with unpleasant dreams. Patients often visit doctors complaining of hurting themselves or their bed partners during sleep. RBD tends to occur in older males and is of concern due to its link to Parkinson's disease and other synucleinopathies. When RBD occurs in association with other neurological or general medical conditions, or results from substance use, it is called secondary RBD. The most common cause of secondary RBD is neurodegenerative illness, specifically synucleinopathies.

The correlation between RBD and synucleinopathies is very strong, with an estimated conversion rate from RBD to a neurodegenerative syndrome of 6.3% per year, and a total of 74% converting after a 12-year follow-up. The risk for developing neurodegenerative diseases was 33.5% at five years of follow-up, 82.4% at 10.5 years, and 96.6% at 14 years. Symptoms of RBD may precede neurodegenerative disorders by decades, and the onset of RBD often precedes the development of neurodegeneration by several years.

The strongest correlation exists between RBD and comorbid neurodegenerative alpha-synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. RBD has also been associated with other non-synucleinopathies, such as progressive supranuclear palsy, familial amyotrophic lateral sclerosis, frontotemporal dementia, and myotonic dystrophy. Additionally, RBD has been linked to Wilson's disease, cerebellar degeneration, and autoimmune encephalitis.

The pathogenesis of RBD is distinct in cases of narcolepsy, as it is linked to orexin deficiency. RBD with concomitant narcolepsy may be considered a distinct phenotype, characterised by less violent or complex behaviour during REM sleep, earlier age of onset, equal sex distribution, and hypocretin (orexin) deficiency. After neurodegenerative diseases, narcolepsy type 1 is the second most common cause of secondary RBD.

RBD can be caused by antidepressant use

RBD Caused by Antidepressant Use

Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia that involves dream enactment behaviour and is associated with a loss of atonia during REM sleep. RBD can be very disturbing and may lead to injury to the individual or their sleeping partner. While RBD can occur in people not taking any medications, antidepressants have been linked to an increased risk of developing RBD, especially in older adults.

SSRIs and RBD Risk

Selective serotonin reuptake inhibitors (SSRIs) are a commonly prescribed class of antidepressants. Research suggests that SSRIs may increase the chances of developing RBD, likely due to their effects on serotonin and dopamine signalling in the brain during sleep. Specific SSRIs associated with higher RBD rates include fluoxetine.

SNRIs and RBD

Serotonin-norepinephrine reuptake inhibitors (SNRIs) are another antidepressant class linked to RBD, particularly in older adults. SNRIs that may increase susceptibility to RBD include venlafaxine, duloxetine, and desvenlafaxine.

The Role of Dopamine

Dopamine, a neurotransmitter, plays a crucial role in REM sleep and muscle paralysis during that stage. Antidepressants that increase dopamine levels or dopamine receptor binding may disrupt this paralysis, allowing for excess movement and dream enactment. Examples include tricyclic antidepressants like amitriptyline and the NDRI bupropion.

Other Medications and RBD

In addition to antidepressants, other psychiatric medications may also contribute to RBD. These include certain antipsychotics, such as clozapine and olanzapine, as well as medications used to treat Parkinson's disease.

Managing Antidepressant-Related RBD

If you experience RBD symptoms like yelling or falling out of bed while taking an antidepressant, consult your doctor. They may recommend adjusting your dosage, switching medications, or prescribing treatments specifically for RBD, such as melatonin or clonazepam.

Lifestyle changes can also help reduce RBD episodes and prevent injuries:

• Remove hazardous objects from the bed area
• Use bed rails or position your mattress on the floor
• Sleep separately from your bed partner if violent behaviours pose safety risks
• Avoid sleep deprivation, which can worsen RBD
• Refrain from alcohol, sedatives, or other substances that may exacerbate RBD

RBD can be diagnosed through a sleep study

REM sleep behaviour disorder (RBD) is a parasomnia involving dream enactment behaviour associated with a loss of muscle atonia during REM sleep. This can result in violent movements, which may lead to injury to the individual or their sleeping partner. RBD is often associated with other neurodegenerative diseases, such as Parkinson's disease and dementia, and can be induced by certain medications, such as antidepressants.

RBD can be challenging to diagnose, and a detailed sleep history is essential to understanding the nature of the parasomnia. A video-monitored polysomnographic sleep study is often required to confirm the diagnosis. This involves simultaneously recording various physiological variables, such as brain activity, eye movements, muscle activity, heart rate, and blood oxygen levels. The characteristic finding of RBD on polysomnography is REM sleep without atonia, where there is increased muscle activity during REM sleep.

The American Academy of Sleep Medicine's International Classification of Sleep Disorders (ICSD-3) outlines specific criteria that must be met for a diagnosis of RBD. These criteria include repeated episodes of sleep-related vocalisations and complex motor behaviours during REM sleep, confirmed by polysomnography or clinical history. Additionally, polysomnography must show REM sleep without atonia, and the episodes should not be attributed to another sleep disorder, medical condition, mental disorder, or substance use.

In summary, RBD is a complex parasomnia that requires a comprehensive approach to diagnosis. A sleep study is a crucial tool in confirming RBD, as it allows for the direct observation of abnormal behaviours and the exclusion of other sleep disorders. This information, along with a detailed sleep history and clinical evaluation, helps healthcare professionals make an accurate diagnosis and develop an appropriate treatment plan to manage symptoms and prevent injuries.

RBD can be treated with medication and lifestyle changes

REM sleep behaviour disorder (RBD) is a parasomnia disorder characterised by nocturnal complex motor behaviour and polysomnographic REM sleep without atonia. The condition is most common in older adults, with an average age of onset at 61 years. RBD can be treated with medication and lifestyle changes.

Lifestyle Changes

The primary goal of RBD treatment is to reduce the risk of injury to the patient and their bed partner. This involves making changes to the sleeping environment, such as:

• Lowering the bed so it's closer to the floor
• Moving furniture and sharp objects away from the bed
• Placing pillows or padding around the bed frame and headboard
• Using a mattress on the floor next to the bed, or padded bed rails
• Sleeping in a sleeping bag
• Removing dangerous objects such as firearms

If the symptoms are severe, it may be safer for the bed partner to sleep in a separate room.

It is also recommended that people with RBD avoid drinking alcohol, as this can trigger an episode and worsen the condition.

Medications

While there are no medications specifically approved for RBD, certain drugs have been shown to reduce symptoms. These include:

• Melatonin: This is considered the first-line medication for RBD due to its low risk of side effects. A dose of 3-12mg at bedtime is recommended.
• Clonazepam: A sedative that has been found effective in reducing nightmares and dream enactment behaviours. The recommended initial dose is 0.25mg 30 minutes before bedtime, with a gradual increase up to a maximum of 4mg. However, it can cause side effects such as morning sleepiness, increased fall risk, and memory dysfunction.
• Pramipexole: A dopamine agonist primarily used to treat Parkinson's disease and restless leg syndrome. It has shown promise in treating RBD symptoms, as RBD may be a dopaminergic deficiency disorder.

Other medications that have been used to treat RBD include temazepam, lorazepam, zolpidem, zopiclone, donepezil, ramelteon, agomelatine, and cannabinoids.

In summary, RBD can be managed through a combination of lifestyle changes to create a safer sleeping environment and medication to reduce the severity of symptoms.

Frequently asked questions